Document Detail

Interactions between drugs for erectile dysfunction and drugs for cardiovascular disease.
MedLine Citation:
PMID:  12058245     Owner:  NLM     Status:  MEDLINE    
The association of erectile dysfunction (ED) and cardiovascular disease is well-documented in the literature and both conditions share risk factors. Therefore, it is difficult to distinguish the effect of underlying disease and adverse effects of the drugs and/or interactions between ED drugs and drugs implemented for cardiovascular disease. The known interactions of systemic administered drugs for ED with drugs for cardiovascular disease are mainly pharmacodynamic. Thus, nitrates enhance the production of cyclic GMP and combined with phosphodiesterase type-5 inhibitors this can lead to severe hypotension. The same is the case for the treatment with phentolamine in patients treated with beta-adrenoceptor antagonists. Due to increased partial thromboplastin time, the risk of bleeding is enhanced for intracavernous alprostadil injection in heparin-treated patients. Pharmacokinetic interactions of clinical importance have been described for ED drugs with other therapeutic groups such as sildenafil with the antifungal drug, ketoconazole, and apomorphine with the antiparkinson drug, entacapon. Although sildenafil and antihypertensive dihydropyridines like amlodipine are metabolized by the same cytochrome P450 enzyme, CYP3A4 in the liver, the combination of these drugs does not exhibit a synergistic blood pressure lowering action. Unfortunately documentation concerning drug interactions is often poor and occasional.
U Simonsen
Related Documents :
20011925 - Frequency of potential interactions between drugs in medical prescriptions in a city in...
14983725 - Drug interactions: a review and update.
2088205 - A three-dimensional model to analyze drug-drug interactions.
20832765 - Evidence-based management of herb-drug interaction in cancer chemotherapy.
20679505 - Simple model for testing drugs against nonreplicating mycobacterium tuberculosis.
3917885 - Use of the bactec system for drug susceptibility testing of mycobacterium tuberculosis,...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  International journal of impotence research     Volume:  14     ISSN:  0955-9930     ISO Abbreviation:  Int. J. Impot. Res.     Publication Date:  2002 Jun 
Date Detail:
Created Date:  2002-06-11     Completed Date:  2002-12-04     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9007383     Medline TA:  Int J Impot Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  178-88     Citation Subset:  IM    
Department of Pharmacology, University of Aarhus, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiovascular Diseases / drug therapy*
Drug Interactions
Erectile Dysfunction / drug therapy*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Significant decrease of the International Index of Erectile Function in male renal failure patients ...
Next Document:  A shared care approach to the management of erectile dysfunction in the community.